Biotech Hangout
Episodes
Episode 64
03 Jul 2023
Contributed by Lukas
On this week’s episode of Biotech Hangout, hosts Daphne Zohar, Tim Opler, Chris Garabedian, Mike Yee and Bruce Booth discuss the week’s industry n...
Episode 63
23 Jun 2023
Contributed by Lukas
This week, hosts Daphne Zohar, Brad Loncar, Tim Opler & Michal Preminger focus on the theme of people and reputation in the industry. The hosts (a...
Episode 62
14 Jun 2023
Contributed by Lukas
This week, Daphne Zohar, Brad Loncar and John Maraganore hosted a special live edition of Biotech Hangout at the BIO conference, and they dive into th...
Episode 61
06 Jun 2023
Contributed by Lukas
On Biotech Hangout this week, hosts Daphne Zohar, Josh Schimmer, Tim Opler, Chris Garabedian and Brad Loncar talk the latest biotech news. Several of ...
Episode 60
24 May 2023
Contributed by Lukas
On this week’s Biotech Hangout, hosts Daphne Zohar, Mike Yee, Otello Stampacchia, Brad Loncar and Bruce Booth discuss the latest in the biopharma in...
Episode 59
16 May 2023
Contributed by Lukas
On this week’s Biotech Hangout, hosts Daphne Zohar, Tim Opler, Josh Schimmer, Bruce Booth, John Maraganore and Sam Fazeli talk the latest industry n...
Episode 58
02 May 2023
Contributed by Lukas
Special guest Praveen Tipirneni, CEO of Morphic, joins Daphne Zohar, Tim Opler, Josh Schimmer, Rob Perez and John Maraganore on this week’s Biotech ...
Episode 57
24 Apr 2023
Contributed by Lukas
On this week’s episode of Biotech Hangout, CEO of Bellus Health (announced this week that GSK is acquiring for $2B), Roberto Bellini, joins hosts Da...
Episode 56
18 Apr 2023
Contributed by Lukas
On this week’s episode of Biotech Hangout, hosts Daphne Zohar, Josh Schimmer, Tim Opler, Michal Preminger and Brad Loncar discuss the latest industr...
Episode 55
06 Apr 2023
Contributed by Lukas
This week on Biotech Hangout, hosts Daphne Zohar, Josh Schimmer, Tim Opler and Sam Fazeli discuss the latest in the biopharma industry from market upd...
Episode 54
29 Mar 2023
Contributed by Lukas
On Biotech Hangout this week, hosts Daphne Zohar, Josh Schimmer, Rob Perez, Sam Fazeli and Mike Yee discuss market sentiment after the fallout from Si...
Episode 53
21 Mar 2023
Contributed by Lukas
On this week’s episode of Biotech Hangout, For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug author, Nathan Vardi, jo...
Episode 52
13 Mar 2023
Contributed by Lukas
On this week’s episode, hosts Daphne Zohar, Josh Schimmer, Tim Opler and Sam Fazeli discuss the fall of Silicon Valley Bank (SVB), private financing...
Episode 51
13 Mar 2023
Contributed by Lukas
On Biotech Hangout this week, hosts Daphne Zohar, Josh Schimmer and Brad Loncar are joined by Andy Plump, President, Research & Development at Tak...
Episode 50
03 Mar 2023
Contributed by Lukas
This week, Paul Hastings, Chief Executive Officer and President of Nkarta Therapeutics and Chair of the Biotechnology Innovation Organization (BIO), j...
Episode 49
22 Feb 2023
Contributed by Lukas
On Biotech Hangout this week, hosts Daphne Zohar, Tim Opler, Chris Garabedian, Bruce Booth and Michal Preminger are joined by Andy Plump, President, R...
Episode 48
14 Feb 2023
Contributed by Lukas
This week’s Biotech Hangout theme is, “the good, the bad, the ugly” … and the “interesting.” Starting with “the good,” hosts Daphne Zo...
Episode 47
06 Feb 2023
Contributed by Lukas
This week, hosts Daphne Zohar, Josh Schimmer, Dawn Bell and Sam Fazeli cover recent biotech earnings, big pharma revenue drivers, FDA news, data and m...
Episode 46
06 Feb 2023
Contributed by Lukas
On this week’s episode, hosts Daphne Zohar and Josh Schimmer welcome founder and former CEO of Alnylam, John Maraganore, as a guest, and are joined ...
Episode 45
30 Jan 2023
Contributed by Lukas
On this week’s episode, hosts Daphne Zohar, Bruce Booth, Dawn Bell and Tim Opler are joined by Rajiv Kaul, portfolio manager in the equity division ...
Episode 44
19 Jan 2023
Contributed by Lukas
On the two-year anniversary of the launch of Biotech Hangout (formerly Biotech Clubhouse), Daphne and Josh are joined by Chris Garabedian an...
Episode 43
11 Jan 2023
Contributed by Lukas
On the first Biotech Hangout episode of 2023, Daphne, Josh, and Tim are joined by Jefferies’ biotech analyst Michael Yee to recap the deals, financi...
Episode 42
16 Dec 2022
Contributed by Lukas
This week, hosts Daphne, Chris, Tim and Dawn are joined by Jeb Keiper, CEO of Nimbus Therapeutics, and by Melanie Senior, Biopharma reporter and analy...
Episode 41
16 Dec 2022
Contributed by Lukas
Hosts Daphne, Josh, Tim and Otello are joined by special guest and biotech investor, Brad Loncar, to discuss the current M&A landscape, data annou...
Episode 40
07 Dec 2022
Contributed by Lukas
In this week’s episode, Daphne, Josh and Tim are joined by Michal Preminger, Head of Johnson & Johnson Innovation, and Jacob Plieth, Evaluate Va...
Episode 39
28 Nov 2022
Contributed by Lukas
Jeremy Levin, Bruce Booth, Rob Perez, Dawn Bell and Ethan Perlstein join Daphne and Josh to discuss the macro biotech picture, recap the recent Jeffer...
Episode 38
16 Nov 2022
Contributed by Lukas
In this episode, Daphne, Josh, Bruce and Dawn are joined by guest Sam Fazeli (Bloomberg) to discuss this week’s biotech news and trends, including p...
Episode 37
07 Nov 2022
Contributed by Lukas
In this episode, Daphne, Bruce, Tim and guest Jefferies’ Michael Yee discuss the latest happenings in biotech, including recent key earnings, clinic...
Episode 36
07 Nov 2022
Contributed by Lukas
Lots of news this week! Daphne, Josh and Ethan discuss key binary events of the week, consolidation and the loss of ~40 companies across the industry ...
Episode 35
28 Oct 2022
Contributed by Lukas
Rob Perez joins Daphne Zohar and Josh Schimmer to discuss the week's deals, data & FDA actions. Special guests include Kevin Judice, CEO of DiCE T...
Episode 34
25 Oct 2022
Contributed by Lukas
Hosts Josh Schimmer, Daphne Zohar and Tim Opler talk conflicts of interest in the industry, the Wall Street Journal’s investigation into the FTC and...
Episode 33
25 Oct 2022
Contributed by Lukas
Hosts Daphne Zohar, Josh Schimmer and Bruce Booth discuss the recent rally in biotech and short interest stocks, when pharma doesn’t opt in or termi...
Episode 32
05 Oct 2022
Contributed by Lukas
Paul Rennert, CEO, President and CSO of Aleta Biotherapeutics joins hosts Daphne Zohar, Brad Loncar and Chris Garabedian to discuss access to research...
Global Access Strategies: COVID Vaccines and Other Meds
09 Jun 2021
Contributed by Lukas
This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts explo...
Good is the New Cool with Afdhel Aziz
09 Jun 2021
Contributed by Lukas
Companies can change the world for the better while advancing their own business goals by supporting community-building activities. Featuring Life Sci...
Pre-ASCO Discussion: Perspectives on Emerging Oncology Treatments
21 May 2021
Contributed by Lukas
A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO....